The Peak Daily Wake me up inside ⏰- Canada’s IPO market comes back to life, A Canadian billionaire’s grand folly.
Feb 26, 2026
Canada's IPO market revives with a planned $1 billion TSX listing and optimism for a stronger 2026 pipeline. A deep dive into Lawrence Stroll's costly missteps at Aston Martin and the team's financial and racing struggles. Ottawa weighs regulation of an AI firm over safety reporting. Quick hits on insider-trading fines, trade talks about tariffs, and headlines on housing, AI data centers, and foreign aid.
AI Snips
Chapters
Transcript
Episode notes
Apotex $1B IPO Signals Canadian Market Revival
- Apotex plans up to a $1 billion IPO on the TSX, potentially the largest Canadian offering in five years.
- Analysts say this and pipeline names like Xanadu and General Fusion signal Canada's IPO market may finally recover since 2021's boom.
Apotex's Troubled Backstory Still Lingers
- Apotex's founder Barry Sherman was murdered in 2017, the case remains unsolved and the firm was later sold to SK Capital.
- That backstory frames the company's path from family ownership to a private equity-led IPO attempt.
Strongest IPO Pipeline Since 2021
- TSX saw a record 42 IPOs in 2021 but only a trickle afterward; 2026's pipeline is the strongest BMO's ECM head has seen since then.
- High-profile listings and rumored names like WestJet would be a vote of confidence amid US relocation pressures.